Clinical Laboratories May Lose SARS-CoV-2 Testing Volumes to Veterinarian Labs
Implications of blurring the lines between human testing laboratories and veterinarian labs.
COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
Implications of blurring the lines between human testing laboratories and veterinarian labs.
With this recently approved testing paradigm that has emerged within the last few weeks, a significant question remains.
Though questions may remain about the reach and risks of the digital technologies used for COVID-19 contact tracing systems, clinical laboratory directors and pathologists will need to watch for changes in test demand.
Topics include adopting a platform that already has an FDA EUA, validating rapid test kits for use at remote sites, and other coronavirus antibody cross reactivity.
Some COVID-19 serology testing methods are demonstrating inadequate performance, according to Sten Westgard, who explained study data during a May 21 webinar. Learn how to assess fast-moving developments.
Mayo Clinic Laboratories is examining if utilization of SARS-CoV-2 serology testing may be optimized when coupled with PCR testing. Dr. Matthew J. Binnicker explains the lab test utilization strategy being evaluated to develop risk profiles and increase risk awareness.
Implications of blurring the lines between human testing laboratories and veterinarian labs.
With this recently approved testing paradigm that has emerged within the last few weeks, a significant question remains.
Though questions may remain about the reach and risks of the digital technologies used for COVID-19 contact tracing systems, clinical laboratory directors and pathologists will need to watch for changes in test demand.
Topics include adopting a platform that already has an FDA EUA, validating rapid test kits for use at remote sites, and other coronavirus antibody cross reactivity.
Some COVID-19 serology testing methods are demonstrating inadequate performance, according to Sten Westgard, who explained study data during a May 21 webinar. Learn how to assess fast-moving developments.
Mayo Clinic Laboratories is examining if utilization of SARS-CoV-2 serology testing may be optimized when coupled with PCR testing. Dr. Matthew J. Binnicker explains the lab test utilization strategy being evaluated to develop risk profiles and increase risk awareness.